Steve Shum - 15 Jan 2022 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Role
Chief Executive Officer, Director
Signature
/s/ Steven Shum
Issuer symbol
IVF
Transactions as of
15 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 20:27:55 UTC
Previous filing
07 Oct 2021
Next filing
12 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Award $0 +20,111 +32% $0.000000 82,035 15 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INVO Stock Option Award $0 +57,018 $0.000000 57,018 15 Jan 2022 Common Stock 57,018 $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in monthly increments over a period of three years from the date of grant.